WSFS
ABCL icon

Wilmington Savings Fund Society’s AbCellera Biologics ABCL Stock Holding History

Wilmington Savings Fund Society’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,968
Closed -$15.5K – 2092
2024
Q3 		$15.5K Buy
+5,968
New +$16.5K ﹤0.01% 1532

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wilmington Savings Fund Society's ABCL Position: Q4 2024 in Review

Wilmington Savings Fund Society sold out of AbCellera Biologics (ABCL) in Q4 2024, closing a stake of 5,968 shares — an estimated $15.5K sold.

Wilmington Savings Fund Society first reported a position in ABCL in Q3 2024 and held it in 1 quarter. The position peaked at $15.5K in Q3 2024. 146 funds tracked by Wall St. Rank hold ABCL as of Q4 2024.

  • Wilmington Savings Fund Society reported no remaining AbCellera Biologics position as of Q4 2024 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 5,968 AbCellera Biologics shares in Q4 2024, an estimated $15.5K.
  • Wilmington Savings Fund Society first reported a position in AbCellera Biologics in Q3 2024 and held it in 1 quarter.
  • Wilmington Savings Fund Society's AbCellera Biologics position peaked at $15.5K in Q3 2024.
  • 146 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2024.

Based on Wilmington Savings Fund Society's 13F filing for Q4 2024, filed 28 Jan 2025.